Palbociclib and Fulvestrant in Breast Cancer. Reply

Nicholas C. Turner; Xin Huang; Massimo Cristofanilli

doi:10.1056/NEJMc1816595

Palbociclib and Fulvestrant in Breast Cancer. Reply

Nicholas C. Turner, Xin Huang, Massimo Cristofanilli

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Number of pages	1
Journal	The New England journal of medicine
Volume	380
Issue number	8
DOIs	https://doi.org/10.1056/NEJMc1816595
State	Published - Feb 21 2019

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMc1816595

Cite this

@article{24c3afcbbd4e40c9ab2bcc7e7d1bb570,

title = "Palbociclib and Fulvestrant in Breast Cancer. Reply",

author = "Turner, {Nicholas C.} and Xin Huang and Massimo Cristofanilli",

year = "2019",

month = feb,

day = "21",

doi = "10.1056/NEJMc1816595",

language = "English (US)",

volume = "380",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "8",

}

TY - JOUR

T1 - Palbociclib and Fulvestrant in Breast Cancer. Reply

AU - Turner, Nicholas C.

AU - Huang, Xin

AU - Cristofanilli, Massimo

PY - 2019/2/21

Y1 - 2019/2/21

UR - http://www.scopus.com/inward/record.url?scp=85062050465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062050465&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1816595

DO - 10.1056/NEJMc1816595

M3 - Letter

C2 - 30786200

AN - SCOPUS:85062050465

SN - 0028-4793

VL - 380

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 8

ER -

Palbociclib and Fulvestrant in Breast Cancer. Reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this